Welcome to the e-CCO Library!

DOP042: Need for ileocaecal resections, but not ileo-colic re-resections, has decreased: a nationwide study of temporal trends in Crohn surgery in Sweden 1990–2014
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Kalman1*, C. Nordenvall2, A. Hallqvist Everhov3, M.C. Sachs4, J.F. Ludvigsson5, A. Ekbom6, P. Myrelid1, O. Olén7

Created: Thursday, 21 February 2019, 9:14 AM
DOP042: Omentectomy is not necessary during laparoscopic total coloproctectomy and ileal pouch-anal anastomosis for inflammatory bowel disease. A comparative study in 247 consecutive patients from 4 expert centres
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mege D.*1, Germain A.2, Stellingwerf M.3, Colombo F.4, Maggiori L.1, De Buck van Overstraeten A.2, Buskens C.3, Foschi D.4, Sampietro G.4, Bemelman W.3, D'Hoore A.2, Panis Y.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP043: Comparative outcomes of ileal pouch revision vs. excision for pouch failure within the American College of Surgeon National Surgical Quality Improvement Programme
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Holubar1*, P. Neary2, S. Shawki2, A. Aiello2, C. Delaney2, S. Steele2, T. Hull2, L. Stocchi2

Created: Thursday, 21 February 2019, 9:14 AM
DOP043: High risk of pouch dysplasia in IBD-PSC patients following total proctocolectomy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Palmela C.*1,2, Castaneda D.3, Shah S.1, ten Hove J.4, Ullman T.1, Itzkowitz S.H.1, Torres J.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
DOP043: Nonadherence to anti-TNF therapy predicts clinical outcomes in outpatients with inflammatory bowel disease: results from a prospective multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. van der Have*1, B. Oldenburg1, A. A. Kaptein2, J. M. Jansen3, R. C. Scheffer4, S. A. van Tuyl5, A. E. van der Meulen - de Jong6, M. Pierik7, P. D. Siersema1, M. G. van Oijen1, 8, H. H. Fidder1

Created: Friday, 22 February 2019, 9:49 AM
DOP044: Efficacy, safety and long-term outcome of endoscopic dilation therapy for Crohn’s disease strictures of the upper gastrointestinal tract: an international multicentre cohort study including 99 patients with 129 dilation procedures
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Bettenworth1,2*, M. Mücke3, A. Singh4, R. Lopez5, M. Goetz6, T. Matsui7, J.G. Karstensen8, N.S. Ding9, T.B. Qiu9, J. Hampe10, K. Matthes10, P.V. Valli111, F. Guo12, W. Zhu13, G. Rogler11, F. Rieder14,15

Created: Thursday, 21 February 2019, 9:14 AM
DOP044: Relationship between microbiota and development of early postoperative Crohn's disease recurrence
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Machiels K.*1, Pascal V.2, Sabino J.1, Santiago A.2, Campos D.2, Wolthuis A.3, De Buck van Overstraeten A.3, D'Hoore A.3, Van Assche G.1, Ferrante M.1, Rutgeerts P.1, Manichanh C.2, Vermeire S.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP044: Self-administered telemedicine reduces number of outpatient visits and days of absence from school in paediatric and adolescent patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Carlsen*1, 2, C. Jakobsen2, L. F. Hansen2, A. Paerregaard2, L. B. Riis3, P. S. Munkholm4, V. Wewer2

Created: Friday, 22 February 2019, 9:49 AM
DOP045: Combination therapy with anti-TNF and immunosuppressive therapies is the most effective medication to prevent and treat endoscopic postoperative recurrence in patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Buisson1,2*, L. Cannon3, K. Umanskiy3, R.D. Hurst3, N.H. Hyman3, A. Sakuraba4, J. Pekow4, S. Dalal4, R.D. Cohen4, B. Pereira5, D.T. Rubin4

Created: Thursday, 21 February 2019, 9:14 AM
DOP045: Post-operative complications in elderly-onset inflammatory bowel disease: a population-based study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sacleux S.-c.*1, Charpentier C.1, Sarter H.2, Fumery M.3, Guillon-Dellac N.4, Laberenne E.5, Pariente B.6, Peyrin-biroulet L.7, Gower-Rousseau C.8, Savoye G.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP045: Self-administered telemedicine empowers paediatric and adolescent patients with Inflammatory Bowel Disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Carlsen*1, 2, C. Jakobsen2, L. F. Hansen2, A. Paerregaard2, T. Kallemose3, G. Houen4, L.B. Riis5, P. S. Munkholm6, V. Wewer2

Created: Friday, 22 February 2019, 9:49 AM
DOP046: Genome-wide association study of baseline disease characteristics and response to Ustekinumab in moderate to severe Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Hart A., Li K., Gasink C., Jacobstein D., Brodmerkel C.

Created: Wednesday, 20 February 2019, 10:36 AM
DOP046: Higher serum concentrations of vedolizumab are associated with superior endoscopic outcomes in Crohn’s disease: data from the LOVE-CD trial
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Berends1,2*, M. Löwenberg2, F. Baert3, R. Mathôt1, E. Clasquin2, C. Van Der Woude4, F. Hoentjen5, P. Bossuyt6, D. Franchimont7, T. Rispens8,9, A. De Vries9, S. Vermeire10, G. D'Haens2

Created: Thursday, 21 February 2019, 9:14 AM
DOP046: Mid- to long-term stability and associated prognostic factors of adalimumab treatment for 1 189 patients with Crohns disease: a multicentre cohort study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H. Tanaka*1, N. Kamata2, A. Yamada3, K. Endo4, T. Fujii5, T. Yoshino6, 7, T. Sugaya8, Y. Yokoyama9, S. Bamba10, J. Umeno11, Y. Yanai12, M. Ishii13, T. Kawaguchi14, S. Shinzaki15, Y. Toya16, T. Kobayashi17, M. Nojima18, T. Hibi17

Created: Friday, 22 February 2019, 9:49 AM
DOP047: Early fibrostenosis in Crohn's disease is associated with multiple susceptibility loci on Immunochip analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Holvoet T.*1, Bossuyt P.2,3, Cleynen I.3, De Kock I.4, Hindryckx P.1, Vermeire S.3,5, Laukens D.1, De Vos M.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP047: Infliximab exposure predicts superior endoscopic outcomes in patients with active Crohn’s disease: pharmacokinetic–pharmacodynamic analysis of TAILORIX
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Dreesen1*, G. D'Haens2, F. Baert3, B. Pariente4, Y. Bouhnik5, J. vander Woude6, J. Moreau7, D. Laharie8, S. Vermeire9,10, A. Gils1

Created: Thursday, 21 February 2019, 9:14 AM
DOP047: PYRAMID registry: an observational study of adalimumab in Crohns disease—results at year 7
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. D’Haens1, W. Reinisch*2, J. Satsangi3, E. Loftus Jr4, R. Panaccione5, H. Read6, M. Heinrich7, J. Petersson6, A.M. Robinson6

Created: Friday, 22 February 2019, 9:49 AM
DOP048: Delayed response to golimumab therapy: UC patient characteristics and long-term clinical outcome—post-hoc analyses from the PURSUIT programme
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J.-F. Colombel*1, W. Reinisch2, P. Gibson3, W. J. Sandborn4, B. Feagan5, S. Xu6, R. Strauss6, H. Zhang6, D. Tarabar7, Z. Hebzda8, P. Rutgeerts9, C. Marano6

Created: Friday, 22 February 2019, 9:49 AM
DOP048: PROFILE trial: predicting outcomes for Crohn's disease using a molecular biomarker
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lee J.1,2, Biasci D.1, Noor N.*1,2, McKinney E.1, Ahmad T.3,4, Lewis N.5, Hart A.6,7, Lyons P.1, Parkes M.1,2, Smith K.1

Created: Wednesday, 20 February 2019, 10:36 AM
DOP048: Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Yarur1*, A. Bruss1, C. Fox1, P. Beniwal-Patel1, A. Patel1, B. Berens1, S. Naik2, D. Stein1

Created: Thursday, 21 February 2019, 9:14 AM